A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT07368023 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07368023
- Sponsor
- Ningbo Medical Center Lihuili Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-25
- Primary completion
- 2026-01-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.